[1] Kong P, Christia P, Frangogiannis NG. The pathogenesis of cardiac fibrosis[J]. Cell Mol Life Sci,2014,71(4):549-574.
[2] Frangogiannis NG. Cardiac fibrosis: cell biological mechanisms, molecular pathways and therapeutic opportunities[J]. Mol Aspects Med, 2019, 65:70-99.
[3] Fu X, Liu Q, Li C, et al. Cardiac fibrosis and cardiac fibroblast lineage-tracing: recent advances [J]. Front Physiol, 2020, 11:416.
[4] Wanh ZhL, Zhang Y, Wang J. The role of Nogo-A and its receptor in Alzheimer’s disease [J]. Acta Anatomica Sinica, 2018, 49 (4): 549-555.(in Chinese)
王兆伦, 张艳, 王君. Nogo-A及其受体在阿尔茨海默病中的作用[J].解剖学报,2018,49(4):549-555.
[5] Schwab ME, Strittmatter SM. Nogo limits neural plasticity and recovery from injury [J]. Curr Opin Neurobiol,2014,27:53-60.
[6] Teng FY, Tang BL. Nogo signaling and non-physical injury-induced nervous system pathology [J]. J Neurosci Res,2005,79(3):273-278.
[7] Li J, Wu W, Xin Y, et al. Inhibition of Nogo-B promotes cardiac hypertrophy via endoplasmic reticulum stress[J]. Biomed Pharmacother, 2018, 104:193-203.
[8] Weng L, Jia S, Xu C, et al. Nogo-C regulates post myocardial infarction fibrosis through the interaction with ER Ca2+ leakage channel Sec61α in mouse hearts[J]. Cell Death Dis, 2018,9(6):612.
[9] Chen MS, Huber AB, van der Haar ME, et al. Nogo-A is a myelin -associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1[J]. Nature, 2000,403(6768):434-439.
[10] Tang J, Huang J, Wu LSh. Study on Nogo, a central nerve regeneration inhibitor [J]. Journal of Neuroanatomy, 2006, (3):362-364.(in Chinese)
唐娟,黄瑾,吴亮生.中枢神经再生抑制因子-Nogo的研究[J].神经解剖学杂志, 2006,(3):362-364.
[11] Schwab ME. Functions of Nogo proteins and their receptors in the nervous system[J]. Nat Rev Neuro sci, 2010, 11(12):799-811.
[12] Bullard TA, Protack TL, Aguilar F, et al. Identification of Nogo as a novel indicator of heart failure[J]. Physiol Genomics, 2008, 32(2):182-189.
[13] Yang M, Tang HT,Ju XH. Research progress of Nogo and nogo-r in central nervous system [J]. Anatomical Research, 2008, (1):65-67.(in Chinese)
杨明,唐洪涛,鞠学红.中枢神经系统中Nogo与Nogo-R的研究进展[J].解剖学研究, 2008,(1):65-67.
[14] Ahamed J, Laurence J. Role of platelet-derived transforming growth factor-β1 and reactive oxygen species in radiation-induced organ fibrosis [J]. Antioxid Redox Signal, 2017,27(13):977-988.
[15] Fournier AE, GrandPre T, Strittmatter SM. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration[J]. Nature, 2001,409(6818):341-346.
[16] Yan J, Zhou X, Guo JJ, et al. Nogo-66 inhibits adhesion and migration of microglia via GTPase Rho pathway in vitro [J]. J Neurochem, 2012,120(5): 721-731.
[17] Liu X, Cui SJ, Zhu SJ, et al. Nogo C contributes to tumorigenesis via suppressing cell growth and its interactome analysis with comparative proteomics research [J]. Int J Clin Exp Pathol, 2014,7(5):2044-2055.
[18] Di Lorenzo A, Manes TD, Davalos A, et al. Endothelial reticulon-4B (Nogo-B) regulates ICAM-1-mediated leukocyte transmigration and acute inflammation[J]. Blood, 2011,117(7):2284-2295.
[19] Okazaki K, Yanagawa M, Mitsuyama T, et al. Recent advances in the concept and pathogenesis of IgG4-related disease in the hepato-bilio-pancreatic system[J]. Gut Liver, 2014, 8(5):462-470.
[20] Zhang D, Utsumi T, Huang HC, et al. Reticulon 4B (Nogo-B) is a novel regulator of hepatic fibrosis[J]. Hepatology, 2011, 53(4):1306-1315.
[21] Jia S, Qiao X, Ye J, et al. Nogo-C regulates cardiomyocyte apoptosis during mouse myocardial infarction[J]. Cell Death Dis, 2016,7(10):e2432.
[22] Baya Mdzomba J, Joly S, Rodriguez L, et al. Nogo-A-targeting antibody promotes visual recovery and inhibits neuroinflammation after retinal injury[J]. Cell Death Dis, 2020, 11(2):101.
[23] Gao HC, Zhao H, Zhang WQ, et al. The role of the Rho/Rock signaling pathway in the pathogenesis of acute ischemic myocardial fibrosis in rat models [J]. Exp Ther Med, 2013,5(4):1123-1128.
[24] Wang YX, da Cunha V, Martin-McNulty B,et al. Inhibition of Rho-kinase by fasudil attenuated angiotensin Ⅱ-induced cardiac hypertrophy in apolipoprotein E deficient mice[J]. Eur J Pharmacol, 2005,512(2-3):215-222.
[25] Ran X, Zhao JX, Nie H, et al. Effects of fluoxetine on Nogo expression and collagen production with decrease of pulmonary artery pressure in rats with right ventricular failure[J]. Journal of Sichuan University(Medical Science Edition), 2016,47(6):857-861. (in Chinese)
冉迅, 赵建洵, 聂虎, 等. 氟西汀对大鼠在心衰竭肺动脉高压的影响及机制探讨[J]. 四川大学学报(医学版), 2016, 47(6): 857-861.
[26] Mohammed R, Opara K, Lall R, et al. Evaluating the effectiveness of anti-Nogo treatment in spinal cord injuries[J]. Neural Dev, 2020, 15(1):1.
[27] Li DD, Song JN, Pang HG, et al. The role of Rho/ROCK pathway in experimental diffuse axonal injury in rats [J]. Journal of Xi’an Jiaotong University (Medical Edition), 2015,36(1):16-22.(in Cinese).
李丹东,宋锦宁,庞宏刚,等.Rho/ROCK通路在大鼠实验性弥漫性轴索损伤中的作用[J].西安交通大学学报(医学版), 2015,36(1):16-22.
[28] Nieder ?st B, Oertle T, Fritsche J, et al. Nog-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1[J]. J Neuro Sci, 2002, 22(23):10368-10376.
[29] Satoh K,Fukumoto Y,Shimokawa H.Rho-kinase:important new therapeutic target in Cardiovascular diseases [J].Am J Physiol Heart Circ Physiol, 2011,301(2):H287-296.
[30] Von Harsdorf R, Li PF, Dietz R. Signaling pathways in reactive oxygen species induced cardiomyocyte apoptosis[J]. Circulation, 1999,99(22):2934-2941.
[31] Li M, Qian HB. Research progress on ROS-mediated MAPK signaling pathway and myocardial fibrosis[J]. Journal of Changchun University of Chinese Medicine, 2017, 33(1):166-168.(in Chinese)
李梦,钱海兵. ROS-MAPK信号通路与心肌纤维化的研究进展[J]. 长春中医大学学报, 2017, 33(1):166-168.
[32] Chen C, Du J, Feng W, et al. β-Adrenergic receptors stimulate interleukin-6 production through Epac-dependent activation of PKCδ/p38 MAPK signalling in neonatal mouse cardiac fibroblasts[J]. Br J Pharmacol, 2012,166(2):676-688.
[33] Nie H, Ran X, Zeng Zh. The effect of ligustrazine on Nogo gene regulation of myocardial fibroblast proliferation [J]. Journal of Sichuan University(Medical Science Edition),2012,43(6):843-846.(in Chinese)
聂虎,冉迅,曾智.川芎嗪对Nogo基因调控心肌成纤维细胞增殖作用的影响[J]. 四川大学学报(医学版), 2012, 43(6): 843-846.
[34] Sarkey JP, Chu M, McShane M, et al. Nogo-A knockdown inhibits hypoxia/reoxygenation-induced activation of mitochondrial-dependent apoptosis in cardiomyocytes [J]. J Mol Cell Cardiol, 2011,50(6):1044-1045.
[35] Zhang Y, Huang Y, Cantalupo A, et al. Endothelial Nogo-B regulates sphingolipid biosynthesis to promote pathological cardiac hypertrophy during chronic pressure overload[J]. JCI Insight, 2016,1(5):e85484.
[36] Zhang B, Jiang J, Yue Z, et al. Store-operated Ca2+ entry (SOCE) contributes to angiotensin Ⅱ-induced cardiac fibrosis in cardiac fibroblasts[J]. J Pharmacol Sci, 2016, 132(3):171-180.
[37] Pu Y, Ran X. Research progress of Nogo protein in cardiovascular disease [J]. Progress in Cardiovascular Disease, 2018,39(3):486-489.(in Chinese)
蒲艳,冉迅.Nogo蛋白在心血管疾病中的研究进展[J].心血管病学进展, 2018,39(3):486-489.
|